Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients

Blood

Volumn 89, Issue 8, 1997, Pages 2679-2688

  Bertolini, Francesco ^a   Battaglia, Manuela ^b   Pedrazzoli, Paolo ^b   Da Prada, Gian Antonio ^b   Lanza, Annalisa ^b   Soligo, Davide ^b   Caneva, Lorenza ^b   Sarina, Barbara ^b   Murphy, Scott ^b   Thomas, Terry ^b   Della Cuna, Gioacchino Robustelli ^b  

^a IRCCS   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; STEM CELL FACTOR;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BREAST CARCINOMA; CELL PROLIFERATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MEGAKARYOCYTE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 17144452780     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2679     Document Type: Article

References (26)

1. Wallace EL, Churchill WH, Surgenor DM, An J, Cho G, McGurk S, Murphy L: Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 32:802, 1995
2. Tepler I, Elias L, Smith JW, Hussein M, Rosen G, Chang AY-C, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA: A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87:3607, 1996
3. Gordon MS, McCaskill-Stevens J, Battiato LA, Loewy J, Loesh D, Breeden E, Hoffman R, Beach KJ, Kuca B, Kaye J, Sledge GW: A phase I trial of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87:3615, 1996
4. Molineux G, Hartley C, McElroy P, McCrea C, McNiece IK: Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. Blood 88:366, 1996
5. Bertolini F, Battaglia M, Corsini C, Lazzari L, Soligo D, Zibera C, Thalmeier K: Engineered stromal layers and continuous flow culture enhance multidrug resistance gene transfer in hematopoietic progenitors. Cancer Res 56:2566, 1996
6. Philpott NJ, Turner AJC, Scopes J, Westby M, Marsch JCW, Gordon-Smith EC, Dalgleish AG, Gibson FM: The use of 7-amino actinomycin D in identifying apoptosis: Simplicity of use and broad spectrum of application compared with other techniques. Blood 87:2244, 1996
7. Tomer A, Friese P, Conclin R: Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Blood 74:594, 1989
8. + bone marrow cells) are enriched with megakaryocytes expressing CD4. Blood 87:1353, 1996
9. Choi ES, Nichol JL, Hokom MH, Hornkohl AC, Hunt P: Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85:402, 1995
10. Emerson SG: Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics (review). Blood 87:3082, 1996
11. Berthier R, Valiron O, Schweitzer A, Marguierie G: Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures: Role of TGF-β. Stem Cells 11:120, 1993
12. Schattner M, Lefebvre P, Spanier Mingolelli S, Goolsby CL, Rademaker A, White JG, Foster D, Green D, Cohen I: Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells 14:207, 1996
13. Kaushansky K: Thrombopoietin: The primary regulator of platelet production (review). Blood 86:419, 1995
14. Lazzari L, Bertolini F, Corsini C, Curioni C, Henschler R, Rebulla P, Sirchia G: Interleukin-3, interleukin-6 and interleukin-11 modulate the effect of thrombopoietin and stem cell factor in ex vivo expansion of human megakaryocytic progenitors. Blood 86:699a, 1995 (abstr, suppl 1)
15. Kaushanski K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C: Thrombopoietin, the mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92:3234, 1995
16. Dolzhanskiy A, Karpatkin S, Basch RS: Effect of Tpo, IL-3, IL-6 and SCF on the development of CD41+CD34+ and CD41-CD34+ human megakaryocyte progenitors. Br J Haematol 93:135, 1996 (abstr, suppl 2)
17. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR: A receptor tyrosine kinase specific to hemopoietic stem cell-enriched populations. Cell 65:1143, 1991
18. - cells and maintains progenitor cells in vitro. Blood 87:3563, 1996
19. Keller JR, Bartelmez SH, Sitnicka E, Ruscetti FW, Ortiz M, Gooya JM, Jacobsen SEW: Distinct and overlapping direct effects of macrophage inflammatory protein 1α and transforming growth factor-β on hematopoietic progenitor/stem cell growth. Blood 84:2175, 1994
20. Verfaille CM, Catanzarro PM, Wen-na L: Macrophage inflammatory protein 1α, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 179:643, 1994
21. Bertolini F, Soligo D, Lazzari L, Corsini C, Servida F, Sirchia G: The effect of interleukin 12 in ex-vivo expansion of human hematopoietic progenitors. Br J Haematol 90:935, 1995
22. Reading CL, Gazitt Y, Estrov Z, Juttner C: Does CD34+ cell selection enrich malignant stem cells in B cell (and other) malignancies? J Hematother 5:97, 1996 (letter)
23. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by means of autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
24. + cells in autologous stem cell transplantation for breast cancer. Blood 87:1687, 1996
25. Alcorn MJ, Holyoake TL, Richmond L, Pearson C, Farrell E, Kyle B, Dunlop DJ, Fitzsimons E, Steward WP, Pragnell IB, Franklin IM: CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 14:1839, 1996
26. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:157, 1996